Pacific Biosciences Of California (PACB) Non-Current Debt (2016 - 2022)
Historic Non-Current Debt for Pacific Biosciences Of California (PACB) over the last 12 years, with Q4 2022 value amounting to $500000.0.
- Pacific Biosciences Of California's Non-Current Debt fell 7826.09% to $500000.0 in Q4 2022 from the same period last year, while for Dec 2022 it was $500000.0, marking a year-over-year decrease of 7826.09%. This contributed to the annual value of $500000.0 for FY2022, which is 7826.09% down from last year.
- As of Q4 2022, Pacific Biosciences Of California's Non-Current Debt stood at $500000.0, which was down 7826.09% from $2.3 million recorded in Q4 2021.
- Over the past 5 years, Pacific Biosciences Of California's Non-Current Debt peaked at $15.8 million during Q4 2019, and registered a low of $500000.0 during Q4 2022.
- Moreover, its 4-year median value for Non-Current Debt was $14.1 million (2018), whereas its average is $10.8 million.
- Per our database at Business Quant, Pacific Biosciences Of California's Non-Current Debt soared by 3756.69% in 2018 and then crashed by 7826.09% in 2022.
- Quarter analysis of 4 years shows Pacific Biosciences Of California's Non-Current Debt stood at $14.7 million in 2018, then rose by 7.78% to $15.8 million in 2019, then tumbled by 85.44% to $2.3 million in 2021, then plummeted by 78.26% to $500000.0 in 2022.
- Its Non-Current Debt was $500000.0 in Q4 2022, compared to $2.3 million in Q4 2021 and $15.8 million in Q4 2019.